Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. EFFECT Other Notice of Effectiveness
  4. UPLOAD Other SEC-generated Letter
  5. POSASR Other POSASR
  6. POSASR Other POSASR
  7. POS AM Other Post-effective Amendment for Registration Statement
  8. S-8 POS Other Post-effective Amendment
  9. S-8 POS Other Post-effective Amendment
  10. S-8 POS Other Post-effective Amendment
  11. S-8 POS Other Post-effective Amendment
  12. S-8 POS Other Post-effective Amendment
  13. S-8 POS Other Post-effective Amendment
  14. S-8 POS Other Post-effective Amendment
  15. S-8 POS Other Post-effective Amendment
  16. S-8 POS Other Post-effective Amendment
  17. 8-K12G3 Other 8-K12G3
  18. EFFECT Other Notice of Effectiveness
  19. 4 Grant or award Director acquired 10,985 shares (grant or award)
  20. 4 Grant or award Director acquired 10,985 shares (grant or award)

Page 12 of 64 · 1,278 filings